Lead Partner: Crown Bioscience
Crown Bioscience is a cutting edge translational technology company providing drug discovery and preclinical development services in the areas of oncology, immunology, inflammation, cardiovascular, and metabolic disease. We bring clarity to drug discovery and enable clients around the world to deliver superior clinical candidates. Our premier translational platforms for cancer, inflammation, and metabolic disease help our clients accelerate their new drug development programs.
Hosting Partner: The Jackson Laboratory
The Jackson Laboratory is a leading provider of cancer mouse models and in vivo oncology services and a National Cancer Institute designated Cancer Center. Drawing on decades of research experience we provide capabilities around model selection, husbandry and customizable oncology studies to help clients and researchers evaluate novel anti-cancer therapies. Our diverse oncology study protocols range from traditional xenograft services to PDX cancer models and advanced humanized mouse models for immuno-oncology drug development.
Programme Partner: Genoway
For the past 20 years, genOway has aimed to improve the predictability and reliability of preclinical data by designing models of high physiological relevancy to best meet researchers’ needs. With a catalog of humanized immune checkpoint mouse models, and mice featuring the human immune system, genOway possesses a broad set of tools to help decipher the mechanism of action as well as the efficacy and safety of drugs targeting the immune system. Additionally, genOway owns strong intellectual property rights, combining patents and licensing agreements, enabling the company to provide end users the necessary freedom to operate.
Programme Partner: Miltenyi Biotec
Miltenyi Biotec provides products that advance biomedical research and cellular therapy. Our innovative tools support research from basic research to translational research to clinical application. Our 30 years of expertise includes immunology, stem cell biology, neuroscience, and cancer. Miltenyi Biotec has 2,500 employees in 28 countries.
Spotlight Partner: Labcorp
Labcorp is a leading global life sciences company that provides vital information
to help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. Through our unparalleled diagnostics and drug development capabilities, we provide insights and accelerate innovations to improve health and improve live.
Learn more about and Labcorp at www.Labcorp.com or follow us on LinkedIn and Twitter @Labcorp
Spotlight Partner: Scientist.com
Founded in 2007, Scientist.com is the world's leading and fastest-growing marketplace for outsourced scientific services and products. The marketplace saves time and money and provides access to innovation while maintaining compliance with an organization’s procurement policies. Scientist.com operates private marketplaces for most of the world’s major pharmaceutical companies, over 100 biotechs and the US National Institutes of Health (NIH). The marketplace features 3,800+ registered suppliers offering more than 4,000 research areas across multiple industries.
Spotlight Partner: Hub Organoids
Hub Organoids was founded by the Hubrecht Institute, the University Medical Center Utrecht, and the Royal Netherlands Academy of Arts and Sciences (KNAW) to refine organoid development and foster organoid adoption globally. HUB Organoid Technology represents a paradigm-shift that bridges the gap between the lab and the clinic and effectively brings “patients in the lab” for drug discovery and development, preclinical patient stratification, predictive biomarker discovery, personalized medicine, clinical trials, regenerative medicine, and companion diagnostics applications.
Exhibition Partner: vivoPharm
VIVOPHARM, a Vyant Bio company (NASDAQ:VYNT), is a successful and fast-growing precision contract research organisation (CRO) providing integrated preclinical services from bench to bedside worldwide. We use our experience and expertise to assist in planning and conducting tailored studies, from discovery stages through to clinical.
Networking Partner: Aiforia
Aiforia equips pathologists and scientists in preclinical, academic, and clinical labs with the most powerful deep learning artificial intelligence and cloud-based technology to increase the speed, accuracy, and consistency of analyzing large and complex medical images across a variety of fields from oncology to neuroscience. Aiforia is composed of an ideal mix of scientists experienced in a variety of medical areas from pathology to cancer diagnostics, software developers who collectively hold over 100 years' experience in artificial intelligence, and a business team with backgrounds in the pharmaceutical and biotechnology industries
Networking Partner: Reaction Biology Europe
Reaction Biology Europe is a leading contract research organization for discovery of conventional and immune-modulating drugs in oncology. As an innovation driver in the area of immuno- oncology, we will introduce SubQPerior, an implantation method to overcome common issues such as heterogeneity and ulceration in subcutaneous tumor models. We have partnered with Reaction Biology, an early-stage drug discovery CRO, to provide our customers with a full suite of services for targeted and phenotypic drug discovery approaches. Let’s discover together.